 COPENHAGEN, Denmark, Jan. 10, 2021 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq: ASND, a biopharmaceutical company that utilizes its innovative TransConTM technologies to create product candidates that address unmet medical needs, will provide an update on Vision 3x3 and the companys 2021 key milestones at the 39th Annual J.P. Morgan Healthcare Conference. 